JPY 4661.0
(-0.53%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 99.81 Billion JPY | -4.28% |
2022 | 97.99 Billion JPY | 1.92% |
2021 | 96.15 Billion JPY | 1.15% |
2020 | 95.06 Billion JPY | -2.82% |
2019 | 97.82 Billion JPY | 1.63% |
2018 | 96.25 Billion JPY | 1.16% |
2017 | 95.14 Billion JPY | -0.62% |
2016 | 95.74 Billion JPY | -1.6% |
2015 | 97.3 Billion JPY | 0.87% |
2014 | 96.46 Billion JPY | 3.99% |
2013 | 92.77 Billion JPY | 7.73% |
2012 | 86.11 Billion JPY | 25.1% |
2011 | 68.83 Billion JPY | 3.11% |
2010 | 66.75 Billion JPY | 15.04% |
2009 | 58.02 Billion JPY | 20.66% |
2008 | 48.09 Billion JPY | 6.48% |
2007 | 45.16 Billion JPY | 2.06% |
2006 | 44.25 Billion JPY | -3.51% |
2005 | 45.86 Billion JPY | 12.99% |
2004 | 40.58 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 25.41 Billion JPY | 8.83% |
2023 Q2 | 25.1 Billion JPY | 0.28% |
2023 FY | 93.8 Billion JPY | -4.28% |
2023 Q1 | 25.03 Billion JPY | 2.42% |
2023 Q4 | 23.35 Billion JPY | 0.53% |
2023 Q3 | 23.22 Billion JPY | -7.47% |
2022 Q3 | 24.73 Billion JPY | 0.12% |
2022 Q2 | 24.7 Billion JPY | 2.48% |
2022 Q1 | 24.11 Billion JPY | 1.36% |
2022 FY | 97.99 Billion JPY | 1.92% |
2022 Q4 | 24.44 Billion JPY | -1.2% |
2021 Q2 | 24.56 Billion JPY | 1.81% |
2021 FY | 96.15 Billion JPY | 1.15% |
2021 Q1 | 24.13 Billion JPY | 2.03% |
2021 Q3 | 23.67 Billion JPY | -3.65% |
2021 Q4 | 23.78 Billion JPY | 0.49% |
2020 Q1 | 23.51 Billion JPY | -3.15% |
2020 Q2 | 24.27 Billion JPY | 3.25% |
2020 Q3 | 23.62 Billion JPY | -2.67% |
2020 Q4 | 23.65 Billion JPY | 0.11% |
2020 FY | 95.06 Billion JPY | -2.82% |
2019 Q2 | 24.57 Billion JPY | 1.33% |
2019 Q4 | 24.27 Billion JPY | -1.77% |
2019 FY | 97.82 Billion JPY | 1.63% |
2019 Q1 | 24.25 Billion JPY | -0.41% |
2019 Q3 | 24.71 Billion JPY | 0.55% |
2018 Q3 | 24.32 Billion JPY | 2.2% |
2018 Q4 | 24.35 Billion JPY | 0.12% |
2018 FY | 96.25 Billion JPY | 1.16% |
2018 Q1 | 23.77 Billion JPY | -0.12% |
2018 Q2 | 23.8 Billion JPY | 0.12% |
2017 Q4 | 23.8 Billion JPY | 0.83% |
2017 Q3 | 23.6 Billion JPY | -1.52% |
2017 Q2 | 23.97 Billion JPY | 0.83% |
2017 Q1 | 23.77 Billion JPY | -0.78% |
2017 FY | 95.14 Billion JPY | -0.62% |
2016 Q2 | 24.02 Billion JPY | 0.07% |
2016 Q3 | 23.75 Billion JPY | -1.12% |
2016 FY | 95.74 Billion JPY | -1.6% |
2016 Q4 | 23.95 Billion JPY | 0.86% |
2016 Q1 | 24 Billion JPY | -5.49% |
2015 FY | 97.3 Billion JPY | 0.87% |
2015 Q3 | 23.98 Billion JPY | -0.54% |
2015 Q4 | 25.4 Billion JPY | 5.92% |
2015 Q2 | 24.11 Billion JPY | 1.26% |
2015 Q1 | 23.81 Billion JPY | 0.48% |
2014 Q3 | 24.2 Billion JPY | -0.65% |
2014 Q4 | 23.69 Billion JPY | -2.08% |
2014 FY | 96.46 Billion JPY | 3.99% |
2014 Q1 | 24.2 Billion JPY | 2.47% |
2014 Q2 | 24.36 Billion JPY | 0.63% |
2013 Q2 | 23.12 Billion JPY | 1.47% |
2013 Q4 | 23.62 Billion JPY | 1.7% |
2013 FY | 92.77 Billion JPY | 7.73% |
2013 Q1 | 22.79 Billion JPY | 5.69% |
2013 Q3 | 23.22 Billion JPY | 0.44% |
2012 Q3 | 28.96 Billion JPY | 63.18% |
2012 FY | 86.11 Billion JPY | 25.1% |
2012 Q1 | 17.82 Billion JPY | 2.27% |
2012 Q2 | 17.75 Billion JPY | -0.42% |
2012 Q4 | 21.56 Billion JPY | -25.56% |
2011 Q4 | 17.43 Billion JPY | -0.14% |
2011 FY | 68.83 Billion JPY | 3.11% |
2011 Q1 | 17.23 Billion JPY | 3.2% |
2011 Q2 | 16.7 Billion JPY | -3.09% |
2011 Q3 | 17.45 Billion JPY | 4.5% |
2010 Q1 | 16.35 Billion JPY | 3.56% |
2010 Q4 | 16.7 Billion JPY | -1.46% |
2010 FY | 66.75 Billion JPY | 15.04% |
2010 Q3 | 16.95 Billion JPY | 1.31% |
2010 Q2 | 16.73 Billion JPY | 2.3% |
2009 Q4 | 15.79 Billion JPY | 5.03% |
2009 Q1 | 13.65 Billion JPY | 13.9% |
2009 Q2 | 13.53 Billion JPY | -0.86% |
2009 FY | 58.02 Billion JPY | 20.66% |
2009 Q3 | 15.03 Billion JPY | 11.09% |
2008 Q2 | 11.99 Billion JPY | 0.0% |
2008 Q3 | 12.4 Billion JPY | 3.41% |
2008 Q4 | 11.98 Billion JPY | -3.35% |
2008 FY | 48.09 Billion JPY | 6.48% |
2007 FY | 45.16 Billion JPY | 2.06% |
2006 FY | 44.25 Billion JPY | -3.51% |
2005 FY | 45.86 Billion JPY | 12.99% |
2004 FY | 40.58 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -128.733% |
Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 96.188% |
Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 81.59% |
Shionogi & Co., Ltd. | 197.62 Billion JPY | 49.492% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -2571.505% |
Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | -52.088% |
Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -243.888% |
Eisai Co., Ltd. | 533.01 Billion JPY | 81.273% |
Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -1789.758% |
Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | -51.688% |
Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -115.741% |
Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -763.992% |
Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -1112.549% |
Tsumura & Co. | 48.8 Billion JPY | -104.543% |
Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -199.535% |
Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -410.913% |
Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -56.61% |
Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -688.631% |
Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -146.677% |
KYORIN Holdings, Inc. | 45.39 Billion JPY | -119.885% |
Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -2301.179% |
Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -1579.008% |
SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -1811.221% |
MedRx Co., Ltd | 959 Million JPY | -10308.446% |
Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -3373.431% |
Solasia Pharma K.K. | 1.47 Billion JPY | -6662.669% |
Modalis Therapeutics Corporation | 2.37 Billion JPY | -4110.506% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -313.064% |
Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -181.706% |
Cyfuse Biomedical K.K. | 735.18 Million JPY | -13477.201% |
Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -4321.99% |